Coronavirus Disease 2019 (COVID-19) has caused a global pandemic. Here we profiled the humoral response against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by measuring immunoglobulin (Ig) A, IgM, and IgG against nucleocapsid and spike proteins, along with IgM and IgG antibodies against receptor-binding domain (RBD) of the spike protein and total neutralizing antibodies (NAbs). We tested 279 plasma samples collected from 176 COVID-19 patients who presented and enrolled at different stages of their disease. Plasma dilutions were optimized and based on the data, a single dilution of plasma was used. The mean absorbance at 450 nm was measured for Ig levels and NAbs were measured using geometric mean titers. We demonstrate that more severe cases have a late-onset in the humoral response compared to mild/moderate infections. All the antibody titers continue to rise in patients with COVID-19 over the disease course. However, these levels are mostly unrelated to disease severity. The appearance time and titers of NAbs showed a significant positive correlation to the antibodies against spike protein. Our results suggest the late onset of antibody response as a risk factor for disease severity, however, there is a limited role of antibody titers in predicting disease severity of COVID-19. Lili Ren et al. investigate antibody response from 176 COVID-19 patients who presented different stages of their disease. This study suggests the late onset of antibody response as a risk factor for disease severity and a limited role of antibody titers in predicting the disease severity of COVID-19.
【저자키워드】 SARS-CoV-2, viral infection, 【초록키워드】 COVID-19, coronavirus disease, severe acute respiratory syndrome coronavirus 2, neutralizing antibody, IgG, IgM, Coronavirus disease 2019, coronavirus, antibody, disease severity, Antibody Response, risk factor, severe acute respiratory syndrome Coronavirus, coronavirus 2, Spike protein, global pandemic, infections, Receptor-binding domain, Humoral response, Immunoglobulin, IgG antibodies, nucleocapsid, RBD, severity of COVID-19, Antibody titer, plasma, respiratory, disease, Antibody titers, NAb, Spike proteins, COVID-19 patient, titers, humoral, Dilution, IgM and IgG, geometric mean, appearance time, positive correlation, NAbs, plasma samples, domain, disease course, geometric mean titers, Stage, Severe case, disease severity of COVID-19, plasma sample, Course, was measured, enrolled, tested, was used, collected, caused, the disease, the spike protein, were measured, absorbance, patients with COVID-19, the antibody, 【제목키워드】 COVID-19, severity, humoral, the disease,